Dermatology Medical News about Photodynamic therapy, eyelid basal cell carcinoma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Photodynamic therapy of eyelid basal cell carcinoma
Journal of the European Academy of Dermatology and Venereology, 08/10/09

Kotimaki J – In a study to evaluate the efficacy of photodynamic therapy (PDT) in the treatment of lower eyelid basal cell carcinoma (BCC), it was found that PDT, although experimental in the eyelid area because of the small amount of data and lack of a long-term follow-up, may be considered a promising comprehensive alternative when treating BCC in the eyelid area.

Methods

Histological confirmation of BCC, a detailed demonstration of the technique with an illustrative series of cases, and a review of related literature.

Results

6 pts with lower eyelid BCC were treated with 2 treatment sessions of PDT within a wk.
5 pts had a nodular type and 1 pt had a superficial type of BCC.
Follow-up after treatment continued for 20-36 mos.
No recurrences were observed during follow-up.
All pts were satisfied with the good results and tolerated treatment well without any harm to the eyeball or surrounding skin.

<< Previous
Clinical and Therapeutic Approach to Childhood Acne: An Update

Next >>
Infraorbital Dark Circles: Definition, Causes, and Treatment...